Drug-eluting stents: the panacea for restenosis?

Lim, M C L

Lim, M C L.

Singapore Med J ; 45(7): 300-2, 2004 Jul.

Article in En | MEDLINE | ID: mdl-15221043

Subject(s)

Anti-Bacterial Agents/administration & dosage; Antineoplastic Agents/administration & dosage; Coated Materials, Biocompatible; Coronary Artery Disease/therapy; Coronary Restenosis/prevention & control; Immunosuppressive Agents/administration & dosage; Paclitaxel/administration & dosage; Sirolimus/administration & dosage; Stents; Angioplasty, Balloon, Coronary; Coronary Restenosis/etiology; Cost-Benefit Analysis; Drug Delivery Systems; Humans; Polymers; Randomized Controlled Trials as Topic; Stainless Steel; Stents/adverse effects; Stents/economics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Stents / Paclitaxel / Sirolimus / Coated Materials, Biocompatible / Coronary Restenosis / Immunosuppressive Agents / Anti-Bacterial Agents / Antineoplastic Agents Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Singapore Med J Year: 2004 Document type: Article Country of publication: India

Search on Google

Add to My VHL

XML

PubMed Links